POST Online Media Lite Edition



 

MindMed appoints Francois Lilienthal as chief commercial officer

Christian Fernsby |
New York, N.Y., USA - MindMed, a clinical-stage biopharmaceutical company, has appointed Francois Lilienthal, as chief commercial officer.

Article continues below




Dr. Lilienthal is an accomplished global biopharmaceutical leader and trained physician with over 20 years of experience.

Dr. Lilienthal held several global leadership roles at Merck, leading successful global brand launches for HIV and Hepatitis C.

Dr. Lilienthal served as executive director and United States brand leader at Tibotec.

Dr. Lilienthal has also served as executive director and global marketing leader at the Janssen Pharmaceutical Companies of Johnson & Johnson and director and global marketing leader at Bristol Myers Squibb.

LATEST 5 MOVES FROM New York